Buscar
Mostrando ítems 71-80 de 7222
Identification of aptamers for application in the differential diagnosis of ovarian tumor
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2019)
The role of chromosomal instability in cancer and therapeutic responses
(2018)
Cancer is one of the leading causes of death, and despite increased research in recent years, control of advanced-stage disease and optimal therapeutic responses remain elusive. Recent technological improvements have ...
Organic and Inorganic Nanoparticles for Prevention and Diagnosis of Gastric Cancer
(Bentham, 2015)
Organic and inorganic nanoparticles show great potential for cancer diagnosis and treatment. Because gastric cancer (GC) represents the second most deadly type of neoplasia worldwide, continued research efforts by scientists ...
Memórias íntimas
(Universidade Estadual Paulista (Unesp), 2016-02-26)
Breast cancer is the world's deadliest disease among women. According to the Brazilian National Cancer Institute (INCA), an estimated 57 thousand new cases are expected to be diagnosed in Brazil in 2016. Despite numberless ...
Desenvolvimento de procedimento e análise de imagens térmicas para a identificação do câncer de mama
(Universidade Federal de UberlândiaBRPrograma de Pós-graduação em Engenharia MecânicaEngenhariasUFU, 2016)
Como melhorar o diagnóstico precoce do câncer bucal?
(2017-01-01)
Objective: Oral squamous cell carcinoma (OSCC) is one of the most common malignant neoplasms, with 300,000 new cases annually diagnosed in the world. Although it appears in the fifth position among men in Brazil, late ...
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
(1996-06-22)
Background The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the worldwide epidemiological evidence on the relation between breast cancer risk and use of hormonal contracept ...
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
(1996-06-22)
Background The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the worldwide epidemiological evidence on the relation between breast cancer risk and use of hormonal contracept ...